Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 534,095
  • Shares Outstanding, K 117,126
  • Annual Sales, $ 34,160 K
  • Annual Income, $ -50,620 K
  • 60-Month Beta -0.18
  • Price/Sales 15.91
  • Price/Cash Flow N/A
  • Price/Book 1.74
Trade OABI with:

Options Overview Details

View History
  • Implied Volatility 174.60% ( -56.97%)
  • Historical Volatility 34.12%
  • IV Percentile 98%
  • IV Rank 71.25%
  • IV High 236.78% on 04/19/24
  • IV Low 20.51% on 02/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 30
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 4,113
  • Open Int (30-Day) 4,609

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.20
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -183.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +0.56%
on 04/25/24
5.54 -19.27%
on 04/04/24
-0.84 (-15.73%)
since 03/25/24
3-Month
4.45 +0.56%
on 04/25/24
6.55 -31.67%
on 02/27/24
-1.60 (-26.28%)
since 01/25/24
52-Week
3.14 +42.52%
on 05/11/23
6.72 -33.36%
on 01/09/24
+0.99 (+28.59%)
since 04/25/23

Most Recent Stories

More News
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings

Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.

LGND : 69.80 (-1.69%)
VKTX : 65.66 (+0.91%)
TVTX : 5.20 (-4.59%)
OABI : 4.46 (-2.19%)
OmniAb to Report First Quarter 2023 Financial Results on May 11

OmniAb, Inc. (Nasdaq: OABI) will report financial results for the three months ended March 31, 2023 before the open of the U.S. financial markets on Thursday, May 11, 2023 and will hold a conference call...

OABI : 4.46 (-2.19%)
OmniAb to Participate in Upcoming Investor Conferences in May

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five upcoming investor conferences in May.

OABI : 4.46 (-2.19%)
Do Options Traders Know Something About OmniAb (OABI) Stock We Don't?

Investors need to pay close attention to OmniAb (OABI) stock based on the movements in the options market lately.

OABI : 4.46 (-2.19%)
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2022, and provided operating and partner program updates.

OABI : 4.46 (-2.19%)
LGND : 69.80 (-1.69%)
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, March 30, 2023 and will hold a...

OABI : 4.46 (-2.19%)
Ligand's (LGND) Q4 Sales & Earnings Top, View Raised, Stock Up

Ligand Pharmaceuticals (LGND) announces better-than-expected results in fourth-quarter 2022. Stock is up in the after-market hours in response to the news. Management raises 2023 financial outlook.

JAZZ : 107.44 (-0.81%)
LGND : 69.80 (-1.69%)
TVTX : 5.20 (-4.59%)
OABI : 4.46 (-2.19%)
OmniAb to Participate in Three Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences.

OABI : 4.46 (-2.19%)
OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) reported financial results for the three and nine months ended September 30, 2022 and provided operating and program updates. OmniAb was part of Ligand Pharmaceuticals Incorporated...

OABI : 4.46 (-2.19%)
LGND : 69.80 (-1.69%)
AHPA : 6.13 (-9.26%)
Ligand (LGND) Beats on Q3 Earnings, Lags Sales, Ups '22 Outlook

Ligand (LGND) reports mixed third-quarter 2022 numbers, beating sales estimates but missing out on earnings. Share price rises as management lifts financial guidance for the year.

MRK : 129.19 (+1.72%)
AMGN : 267.87 (-1.88%)
LGND : 69.80 (-1.69%)
OABI : 4.46 (-2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 4.70
2nd Resistance Point 4.66
1st Resistance Point 4.61
Last Price 4.46
1st Support Level 4.52
2nd Support Level 4.48
3rd Support Level 4.43

See More

52-Week High 6.72
Fibonacci 61.8% 5.35
Fibonacci 50% 4.93
Fibonacci 38.2% 4.51
Last Price 4.46
52-Week Low 3.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar